It was reported that an unknown patient underwent an idvt ablation procedure with a thermocool® smart touch® sf uni-directional navigation catheter.The patient suffered cardiac tamponade requiring a pericardiocentesis.It was reported that during a pvc ¿ idvt case, a pericardial effusion was noticed.The patient had a drop in blood pressure and the heart rate decreased gradually after delivering ablation.The pericardial effusion was confirmed by ice.The medical team reported that the medical intervention provided was a pericardiocentesis and 300ml of fluid was removed.The physician believes the ablation catheter may have advanced farther than the boundary of the rvot but could not confirm what may have contributed to the cause of the perforation.The patient was reported to be in stable condition.Outcome of the adverse event was fully recovered (no residual effects).Patient was admitted to the icu after the procedure.Generator information provided was patient interface unit (piu) #11595.No transseptal puncture performed.No evidence of steam pop.Flow setting for the irrigated catheter used was 8 ml/min.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.
|
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|